<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38535">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01918722</url>
  </required_header>
  <id_info>
    <org_study_id>JDZX2012074</org_study_id>
    <secondary_id>JDZX2012074</secondary_id>
    <nct_id>NCT01918722</nct_id>
  </id_info>
  <brief_title>Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy</brief_title>
  <official_title>Clinical Re-evaluation of Removing Blood Stasis Therapy of Herbal Medicine in Treating Acute Cerebral Hemorrhage Safety</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangzhou University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangzhou University of Traditional Chinese Medicine</source>
  <oversight_info>
    <authority>China: State Administration of Traditional Chinese Medicine of the People's Republic of China</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In order to investigate the time window of acute intracerebral hemorrhage(AICH) by &quot;Blood
      Activating and Stasis Dispersing&quot; therapy and to verify traditional methods if it would
      influence or enlarge the brain hematoma, test is made by random double-blind controlled.
      Patients are classified to （0-6h）and (6-72h) teams. Herbs is separated too. The period of
      the therapy lasts two weeks, and the follow up should last three months. The main indexes
      are mortality rate, disability rate and the brain hematoma situation. The review is made by
      the reference to (NIHSS),(GCS) and so on. So, the window time is determined through this
      test.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      objective: to investigate the safety and effect of acute cerebral hemorrhage treated with
      &quot;Blood Activating and Stasis Dispersing&quot; therapy and to verify the traditional methods can
      influence the brain hematoma enlargement or not.

      Methods: from 2013.8 to 2015.12, 360 cases of AICH will be included in 13 research centers.
      Patients are randomly into 3 groups within 6hrs from onset,such as, group A, blood
      activating herbal medicine (8 herbals), Group B, herbal medicine without blood activating
      herbal(6 herbals), Group C, placebo for 10days. All the patients will be treated according
      AHA guideline of AICH. All patients will be set to the CT at the onset, 24h later and
      10-14days after treatment. So the rate of enlargement of brain hematoma in the 72h later,
      mortality rate in the two weeks and the disability rate in the 90 days can be evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Hematoma enlargement</measure>
    <time_frame>24hrs, 10-14days</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>fatality rate</measure>
    <time_frame>3 month</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>modified rankin scale</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>National Institute of Health of stroke scale</measure>
    <time_frame>10-14days, 90days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Intracerebral Hemorrhage</condition>
  <arm_group>
    <arm_group_label>ICH-1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>herbal medicine with Hirudo, Tabanus,8 herbals, promote blood circulation function</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICH-2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>herbal medicine without Hirudo, Tabanus,Only 6 herbals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo herbal medicine</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo ：granula，dose twice a day by Oral or nasogastric tube for 10 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ICH-1(herbal medicine with Hirudo, Tabanus)</intervention_name>
    <description>8herbals (with 2 herbals of Activating blood stagnation and expelling blood stasis herbs) one dose, bid, for 10 days</description>
    <arm_group_label>ICH-1</arm_group_label>
    <other_name>PXZY</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo herbal medicine, one dose,bid, for 10 days</description>
    <arm_group_label>placebo herbal medicine</arm_group_label>
    <other_name>pxzyp</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ICH-2(herbal medicine without Hirudo, Tabanus)</intervention_name>
    <description>(6herbals, without 2 herbals of promoting blood stasis) one dose, bid, for 10 days</description>
    <arm_group_label>ICH-2</arm_group_label>
    <other_name>NPXZY</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  no younger than 18 yrs

          -  acute cerebral hemorrhage confirmed by brain CT scan

          -  within 6 hours from onset

          -  GCS≥6

          -  Sign the informed consent form

        Exclusion Criteria:

          -  Tests have confirmed that cerebral hemorrhage caused by brain tumor, blood diseases,
             cerebrovascular malformation (anomaly) or aneurysm, etc;

          -  patients with Severe heart, liver and renal insufficiency.

          -  Intolerance to traditional Chinese medicine (TCM), allergic constitution.

          -  patients with severe cerebral hernia in the early onset

          -  Compliance is poor.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jianwen m Guo, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guangdong Province Hospital of Tradtional Chinese Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jianwen Guo, doctor</last_name>
    <phone>0086-13724899379</phone>
    <email>jianwen_guo@msn.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yefeng Cai, master</last_name>
    <phone>(08620)81887233</phone>
    <phone_ext>34530</phone_ext>
    <email>caiyefeng@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The hospital of Chinese Medicine of Conghua City</name>
      <address>
        <city>Conghua</city>
        <state>Guangdong</state>
        <zip>5109000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiexia li</last_name>
      <phone>13926183618</phone>
      <email>lijie_xia@126.com</email>
    </contact>
    <investigator>
      <last_name>Jiexia Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>songhua xiao, director</last_name>
      <phone>86-20-13802782299</phone>
      <email>docliujun@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>fengying Zhu, investigator</last_name>
      <phone>86-2013719339937</phone>
      <email>stroketcm1518@126.com</email>
    </contact_backup>
    <investigator>
      <last_name>songhua Xiao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guangdong Provincial Hospital of Chinese Medicine</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianwen Guo, MD</last_name>
      <phone>(08620)81887233</phone>
      <phone_ext>34530</phone_ext>
      <email>jianwen_guo@msn.com</email>
    </contact>
    <contact_backup>
      <last_name>Lixin Wang, MD</last_name>
      <phone>(08620)81887233</phone>
      <phone_ext>34530</phone_ext>
      <email>plawlx@126.com</email>
    </contact_backup>
    <investigator>
      <last_name>JIANWEN GUO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guangzhou Hospital of Integrated traditional and west medicine</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510800</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chaojun Chen</last_name>
      <phone>13926297698</phone>
      <phone_ext>020</phone_ext>
      <email>ccjbs@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Jianfang Hu</last_name>
      <phone>15814867166</phone>
      <phone_ext>020</phone_ext>
      <email>hjf5630@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Chaojun Chen</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jianfang Hu</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Panyu Hospital of Chinese Medicine</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>511400</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaiyun Zhu</last_name>
      <phone>13719364328</phone>
      <phone_ext>020</phone_ext>
    </contact>
    <contact_backup>
      <last_name>Ningping Liu</last_name>
      <phone>13660090303</phone>
      <phone_ext>020</phone_ext>
      <email>lnp123@qq.com</email>
    </contact_backup>
    <investigator>
      <last_name>Kaiyun Zhu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boluo County People's Hospital</name>
      <address>
        <city>Huizhou</city>
        <state>Guangdong</state>
        <zip>514610</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guangsheng Chen</last_name>
      <phone>18928355925</phone>
      <phone_ext>0752</phone_ext>
      <email>18928355925@189.cn</email>
    </contact>
    <contact_backup>
      <last_name>Chang Lin</last_name>
      <phone>15018613961</phone>
      <phone_ext>0752</phone_ext>
      <email>37990154@qq.com</email>
    </contact_backup>
    <investigator>
      <last_name>Guangsheng Chen</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chang Lin</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jiangmen Wuyi Traditional Chinese Medicine Hospital</name>
      <address>
        <city>Jiangmen</city>
        <state>Guangdong</state>
        <zip>529000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>qianshan zhao, MD</last_name>
      <phone>13686981584</phone>
      <email>qsmj2004@163.com</email>
    </contact>
    <investigator>
      <last_name>qianshan zhao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lianjiang People's hospital</name>
      <address>
        <city>Lianjiang</city>
        <state>Guangdong</state>
        <zip>524400</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hua Wang</last_name>
      <phone>13729134569</phone>
      <phone_ext>0759</phone_ext>
      <email>zjwanghua2007@163.com</email>
    </contact>
    <investigator>
      <last_name>Hua Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yangjiang Hospital of Traditional Chinese Medicine</name>
      <address>
        <city>Yangjiang</city>
        <state>Guangdong</state>
        <zip>529500</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gan Huang</last_name>
      <phone>13829816352</phone>
      <phone_ext>0662</phone_ext>
      <email>sunqiaojie@163.com</email>
    </contact>
    <investigator>
      <last_name>Gan Huang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zengcheng City Hospital of traditional Chinese Medicine</name>
      <address>
        <city>Zengcheng</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qilan Wang</last_name>
      <phone>13556057528</phone>
      <phone_ext>020</phone_ext>
      <email>gdzcwql@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Huiying Zhu</last_name>
      <phone>13430365694</phone>
      <phone_ext>020</phone_ext>
      <email>Zhuhuiying1980@126.com</email>
    </contact_backup>
    <investigator>
      <last_name>Qilan Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Huiying Zhu</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boji-affiliated Hospital of Sun Yat-sen University</name>
      <address>
        <city>Zengcheng</city>
        <state>Guangdong</state>
        <zip>511300</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianbing Zhong, MD</last_name>
      <phone>13711547120</phone>
      <phone_ext>020</phone_ext>
      <email>zjbrmyy@126.com</email>
    </contact>
    <investigator>
      <last_name>Jianbing Zhong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>1st people's hospital of Yueyang city</name>
      <address>
        <city>Yueyang</city>
        <state>Hunan</state>
        <zip>414000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>luoqing Li, MD</last_name>
      <phone>13873094682</phone>
      <email>luoql99s@163.com</email>
    </contact>
    <investigator>
      <last_name>Luoqing Li, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shenyang No.2 traditional Chinese medical hospital</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhengkun Wang</last_name>
      <phone>13604182559</phone>
      <phone_ext>024</phone_ext>
      <email>Wzk753@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Zhengkun Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>February 28, 2014</lastchanged_date>
  <firstreceived_date>April 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Activating blood stagnation and expelling blood stasis</keyword>
  <keyword>Hematoma enlargement</keyword>
  <keyword>herbal medicine</keyword>
  <keyword>traditional chinese medicine</keyword>
  <keyword>random clinical trial</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Cerebral Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
